Abstract
Yersinia enterocolitica remains a charismatic microorganism. The research findings outlined in this article have uncovered new virulence factors, such as type III secretion systems, and have advanced our understanding of the pathogenesis of gastrointestinal infections caused by Y. enterocolitica. Furthermore, a clarification of the potential capability of biovar 1A strains, long regarded as avirulent, has now proven that they cause symptomatic infections in appropriate patient settings, such as immunosuppression or hemochromatosis. Researchers have also expanded the spectra of non-gastrointestinal clinical manifestations of disease to include cutaneous infections, endocarditis, pneumonia, pharyngitis, and meningitis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
